TCI Wealth Advisors, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$54,026
-21.4%
2,127
+25.6%
0.01%
-30.0%
Q4 2022$68,709
+10.8%
1,694
-9.1%
0.01%0.0%
Q3 2022$62,000
-6.1%
1,8630.0%0.01%0.0%
Q2 2022$66,000
-35.3%
1,863
-15.7%
0.01%
-33.3%
Q1 2022$102,000
-29.7%
2,211
+1.1%
0.02%
-28.6%
Q4 2021$145,000
+8.2%
2,188
+1.7%
0.02%
+5.0%
Q3 2021$134,000
-40.7%
2,151
-21.3%
0.02%
-47.4%
Q2 2021$226,000
+24.2%
2,732
-0.4%
0.04%
-50.6%
Q1 2021$182,000
-13.7%
2,743
-0.2%
0.08%
-18.1%
Q4 2020$211,000
+78.8%
2,7480.0%0.09%
+100.0%
Q3 2020$118,000
-5.6%
2,748
-4.7%
0.05%
-11.3%
Q2 2020$125,000
+50.6%
2,8850.0%0.05%
+29.3%
Q1 2020$83,000
-74.8%
2,885
-44.6%
0.04%
-68.0%
Q4 2019$330,000
+126.0%
5,207
+0.2%
0.13%
+96.9%
Q3 2019$146,000
+4.3%
5,198
-1.9%
0.06%
+3.2%
Q2 2019$140,000
+2233.3%
5,298
+1609.0%
0.06%
+2000.0%
Q1 2019$6,0000.0%310
-39.2%
0.00%
+50.0%
Q4 2018$6,000
+50.0%
510
+142.9%
0.00%0.0%
Q3 2018$4,000
+300.0%
210
+90.9%
0.00%
Q2 2018$1,000110
+1000.0%
0.00%
Q1 2018$0100.0%0.00%
Q4 2017$010
-90.0%
0.00%
Q2 2017$01000.0%0.00%
Q1 2017$0
-100.0%
100
-75.0%
0.00%
-100.0%
Q4 2016$1,000
-87.5%
400
-63.6%
0.00%
-75.0%
Q3 2016$8,000
+14.3%
1,100
-21.4%
0.00%0.0%
Q2 2016$7,0001,4000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders